Cargando…

Efficacy and Safety of Terbinafine 500 mg Once Daily in Patients with Dermatophytosis

INTRODUCTION: Dermatophytosis are the most common fungal infections globally. Terbinafine is considered to have good potency against dermatophytes, but resistance to terbinafine is on the rise. OBJECTIVE: The objective of this study was to evaluate the efficacy and safety of terbinafine 500 mg given...

Descripción completa

Detalles Bibliográficos
Autores principales:	Babu, P Ravindra, Pravin, A J S, Deshmukh, Gaurav, Dhoot, Dhiraj, Samant, Aniket, Kotak, Bhavesh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5527721/ https://www.ncbi.nlm.nih.gov/pubmed/28794551 http://dx.doi.org/10.4103/ijd.IJD_191_17

Ejemplares similares

Author's reply
por: Babu, P Ravindra, et al.
Publicado: (2017)

Rational for Drug Dosimetry and Duration of Terbinafine in the Context of Recalcitrant Dermatophytosis: Is 500 mg Better than 250 mg OD or BD?
por: Sardana, Kabir, et al.
Publicado: (2017)

Extensive Dermatophytosis Caused by Terbinafine-Resistant Trichophyton indotineae, France
por: Jabet, Arnaud, et al.
Publicado: (2022)

Development and Characterization of Terbinafine-Loaded Nanoemulgel for Effective Management of Dermatophytosis
por: Phagna, Mayank, et al.
Publicado: (2023)

Pharmacokinetic and clinical comparison of super-bioavailable itraconazole and conventional itraconazole at different dosing in dermatophytosis
por: Dhoot, Dhiraj, et al.
Publicado: (2023)

Management of Dermatophytosis: Real-World Indian Perspective
por: Shenoy, Manjunath, et al.
Publicado: (2023)

Relapse after Oral Terbinafine Therapy in Dermatophytosis: A Clinical and Mycological Study
por: Majid, Imran, et al.
Publicado: (2016)

Oral Isotretinoin Combined with Oral Terbinafine Versus Oral Terbinafine Alone to Treat Recurrent Dermatophytosis: An Open-Label Randomised Clinical Trial
por: Verma, Kaushal K., et al.
Publicado: (2021)

An Open-Label, Randomized, Double-Arm Clinical Trial to Compare the Effectiveness and Safety of Super Bioavailable Itraconazole Capsules and Itraconazole Capsules in the Management of Dermatophytosis in India
por: Shenoy, Manjunath, et al.
Publicado: (2021)

Effect of fluconazole and terbinafine nanoparticles on the treatment of dermatophytosis induced by Trichophyton mentagrophytes in guinea pig
por: Lalvand, Mahshid, et al.
Publicado: (2021)

Comparison between the efficacy of terbinafine and itraconazole orally vs. the combination of the two drugs in treating recalcitrant dermatophytosis
por: Hassaan, Zinab Rabia Abo Almaati, et al.
Publicado: (2023)

An observational study to monitor the efficacy and tolerability of levofloxacin 500 mg once daily for treatment of chronic bacterial prostatitis in Saudi Arabia
por: El Meliegy, Amr Ismail, et al.
Publicado: (2015)

Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: A randomized, observer-blind, parallel group study
por: Chatterjee, Dattatreyo, et al.
Publicado: (2016)

Comparative Efficacy of Super Bioavailable Itraconazole Capsules 50 mg vs 65 mg Twice Daily in the Management of Glabrous Tinea
por: Shah, Bela, et al.
Publicado: (2023)

Long-term retention on treatment with lumiracoxib 100 mg once or twice daily compared with celecoxib 200 mg once daily: A randomised controlled trial in patients with osteoarthritis
por: Fleischmann, Roy, et al.
Publicado: (2008)

Review of Efficacy and Safety of Duloxetine 40 to 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain
por: Skljarevski, Vladimir, et al.
Publicado: (2012)

Efficacy and safety of duloxetine 60 mg once daily in major depressive disorder: a review with expert commentary
por: Ball, Susan G, et al.
Publicado: (2013)

Duloxetine 60 mg once daily in the treatment of milder major depressive disorder
por: Perahia, DGS, et al.
Publicado: (2006)

Disinfection trials with terbinafine‐susceptible and terbinafine‐resistant dermatophytes
por: Skaastrup, Kristoffer Nagy, et al.
Publicado: (2022)

Naive tinea corporis et cruris in an Immunocompetent adult caused by a geophile Nannizzia gypsea susceptible to Terbinafine–Rarity in the current scenario of Dermatophytosis in India
por: Vanam, Hari Pankaj, et al.
Publicado: (2019)

P115 Reversed-phase high-performance liquid chromatography as rapid and simple method for quantifications of terbinafine drug in human serum from dermatophytosis cases
por: Thakur, Sheetal, et al.
Publicado: (2022)

Terbinafine and Neutropenia
por: Yavaşoğlu, İrfan
Publicado: (2015)

Potential benefit of dolutegravir once daily: efficacy and safety
por: Fantauzzi, Alessandra, et al.
Publicado: (2013)

Efficacy and safety of telithromycin 800 mg once daily for 7 days in community-acquired pneumonia: an open-label, multicenter study
por: Fogarty, Charles M, et al.
Publicado: (2005)

Efficacy and Safety of Tadalafil 5 mg Administered Once Daily in Korean Men with Erectile Dysfunction: A Prospective, Multicenter Study
por: Kang, Dong Hyuk, et al.
Publicado: (2010)

The association between daily 500 mg calcium supplementation and lower pregnancy-induced hypertension risk in Bangladesh
por: Khanam, Fouzia, et al.
Publicado: (2018)

Clinical Acceptability Of Trimetazidine Modified-Release 80 mg Once Daily Versus Trimetazidine Modified-Release 35 mg Twice Daily In Stable Angina Pectoris
por: Pozdnyakov, Yuri M.
Publicado: (2018)

AB167. Efficacy and safety of long-term tadalafil 5 mg once daily combined with sildenafil 50 mg as needed at the early stage of treatment for patients with erectile dysfunction
por: Cui, H, et al.
Publicado: (2014)

Rhabdomyolysis attributed to terbinafine: A rare occurrence that can be mistaken for terbinafine-induced hepatotoxicity
por: Ly, Priscilla, et al.
Publicado: (2018)

Once-daily dosing of gentamicin.
por: Soper, D E
Publicado: (1998)

Animal Model of Dermatophytosis
por: Shimamura, Tsuyoshi, et al.
Publicado: (2012)

Updates on Genital Dermatophytosis
por: Thakur, Rameshwari, et al.
Publicado: (2020)

Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety
por: Derington, Catherine G., et al.
Publicado: (2020)

Efficacy and safety of once daily tacrolimus compared to twice daily tacrolimus after liver transplantation
por: Bzeizi, Khalid Ibrahim, et al.
Publicado: (2021)

Efficacy and Safety of Oral Minoxidil 5 mg Once Daily in the Treatment of Male Patients with Androgenetic Alopecia: An Open-Label and Global Photographic Assessment
por: Panchaprateep, Ratchathorn, et al.
Publicado: (2020)

Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice
por: Gooderham, Melinda J., et al.
Publicado: (2023)

Pharmacokinetics, Safety, and Tolerability of a Single 500-mg or 1000-mg Intravenous Dose of Dalbavancin in Healthy Japanese Subjects
por: Scoble, Patrick J., et al.
Publicado: (2015)

Efficacy and safety of once daily dosing of colistin to critically ill patients
por: Skiada, A, et al.
Publicado: (2010)

Efficacy and safety of once-daily aclidinium in chronic obstructive pulmonary disease
por: Jones, Paul W, et al.
Publicado: (2011)

Brand versus generic dispensing trend for ciprofloxacin 500 mg, levofloxacin 500 mg, and moxifloxacin 400 mg (oral dosage forms) among pharmacies of Karachi, Pakistan
por: Zehra, Fatima, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nl5bohdi5h77tt86qf83obedec